The gel, tested in mice, releases drugs and special antibodies that simultaneously deplete immune-blocking cells called macrophages from the surgical site and activate T cells so they can attack cancer.
News
Canine TV preferences could lead to answers in protecting dogs’ eyesight
A UW study is asking dog owners what their pets like to watch — a nontrivial question that could lay the groundwork for developing better canine eye tests.
In animal studies, maternal sleep apnea risks ‘constellation of deficits’ in male offspring
The findings offer guidance to physicians to help mitigate risk to children of a significant number of expectant parents.
Mouse study may help doctors choose treatments for leukemia patients
By exploring the ways mice responded, researchers hope to gain an understanding of the sorts of human health issues that may bring on a case of this life-threatening form of cancer.
Researchers are using machine learning to understand how brain cells work
Called manifold learning, the approach may help researchers better understand and even predict brain disorders by looking at specific neuronal properties.
Perception study may explain promising depression therapy
Ketamine has been shown to relieve depression-like symptoms in animal studies. With human volunteers, researchers Sounak Mohanta and Yuri Saalmann concluded that the drug blocks “negative predictions” that are prominent in depressed patients.
Microbes help hibernating animals recycle nutrients, maintain muscle through winter
The discovery could help people with muscle-wasting disorders and even astronauts on extended space voyages by putting space travelers into a hibernation-like state.
Current anti-COVID pills work well against omicron, but antibody drugs are less effective
Public health officials expect antiviral pills to become an increasingly common treatment for COVID-19 that will reduce the severity of the disease in at-risk patients and decrease the burden of the pandemic.
UW–Madison researchers lead effort to create a universal coronavirus vaccine
If the world already had a pan-coronavirus vaccine in March 2020, it could have served as a mitigation tool until vaccines specific to SARS-CoV-2 could be developed.
Boosting one gene in the brain’s helper cells slows Alzheimer’s progression in mice
High activity of the gene, Nrf2, slowed cognitive and physical decline in the mice and reduced the accumulation of sticky proteins in their brains, all key markers of the disease in humans.